108 related articles for article (PubMed ID: 23449406)
21. Successful disabling of the 5' UTR of HCV using adeno-associated viral vectors to deliver modular multimeric primary microRNA mimics.
Bourhill T; Arbuthnot P; Ely A
J Virol Methods; 2016 Sep; 235():26-33. PubMed ID: 27181212
[TBL] [Abstract][Full Text] [Related]
22. Efficient adenovirus vector-mediated PPAR gamma gene transfer into mouse embryoid bodies promotes adipocyte differentiation.
Tashiro K; Kawabata K; Sakurai H; Kurachi S; Sakurai F; Yamanishi K; Mizuguchi H
J Gene Med; 2008 May; 10(5):498-507. PubMed ID: 18278825
[TBL] [Abstract][Full Text] [Related]
23. Improving adenovirus vector-mediated RNAi efficiency by lacking the expression of virus-associated RNAs.
Machitani M; Sakurai F; Katayama K; Tachibana M; Suzuki T; Matsui H; Yamaguchi T; Mizuguchi H
Virus Res; 2013 Dec; 178(2):357-63. PubMed ID: 24055658
[TBL] [Abstract][Full Text] [Related]
24. [Fundamental studies of hepatitis C virus: a review].
Fujiyama S; Kawano S
Rinsho Byori; 1992 Sep; 40(9):911-7. PubMed ID: 1331574
[TBL] [Abstract][Full Text] [Related]
25. [Adenovirus-mediated transduction of HBV/C genome into HepG2 cell line].
Zhou B; Liang MF; Li WD; Wang C; Wang ZH; Hou JL
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1764-7. PubMed ID: 18971166
[TBL] [Abstract][Full Text] [Related]
26. [Recent progress in adenovirus vectors: focusing on VA-deleted AdV].
Kondo S; Maekawa A; Saito I; Kanegae Y
Uirusu; 2013; 63(2):155-64. PubMed ID: 25366050
[TBL] [Abstract][Full Text] [Related]
27. A human liver cell line exhibits efficient translation of HCV RNAs produced by a recombinant adenovirus expressing T7 RNA polymerase.
Aoki Y; Aizaki H; Shimoike T; Tani H; Ishii K; Saito I; Matsuura Y; Miyamura T
Virology; 1998 Oct; 250(1):140-50. PubMed ID: 9770428
[TBL] [Abstract][Full Text] [Related]
28. [Development of a novel adenovirus vector exhibiting microRNA-mediated suppression of the leaky expression of adenovirus genes].
Shimizu K; Sakurai F; Tachibana M; Mizuguchi H
Yakugaku Zasshi; 2012; 132(12):1407-12. PubMed ID: 23208048
[TBL] [Abstract][Full Text] [Related]
29. Heterologous Immunity between Adenoviruses and Hepatitis C Virus: A New Paradigm in HCV Immunity and Vaccines.
Singh S; Vedi S; Samrat SK; Li W; Kumar R; Agrawal B
PLoS One; 2016; 11(1):e0146404. PubMed ID: 26751211
[TBL] [Abstract][Full Text] [Related]
30. Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain.
Mikkelsen M; Holst PJ; Bukh J; Thomsen AR; Christensen JP
J Immunol; 2011 Feb; 186(4):2355-64. PubMed ID: 21257961
[TBL] [Abstract][Full Text] [Related]
31. Targeting of high-capacity adenoviral vectors.
Biermann V; Volpers C; Hussmann S; Stock A; Kewes H; Schiedner G; Herrmann A; Kochanek S
Hum Gene Ther; 2001 Sep; 12(14):1757-69. PubMed ID: 11560769
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis C viral RNA: challenges and promises.
Shi ST; Lai MM
Cell Mol Life Sci; 2001 Aug; 58(9):1276-95. PubMed ID: 11577984
[TBL] [Abstract][Full Text] [Related]
33. Transduction with Lentiviral Vectors Altered the Expression Profile of Host MicroRNAs.
Huang H; Zhang C; Wang B; Wang F; Pei B; Cheng C; Yang W; Zhao Z
J Virol; 2018 Sep; 92(18):. PubMed ID: 29997205
[TBL] [Abstract][Full Text] [Related]
34. Biological impact of hepatitis B virus X-hepatitis C virus core fusion gene on human hepatocytes.
Ma Z; Shen QH; Chen GM; Zhang DZ
World J Gastroenterol; 2008 Sep; 14(35):5412-8. PubMed ID: 18803352
[TBL] [Abstract][Full Text] [Related]
35. Genotype 1a HCV (H77S) infection system.
Yi M; Lemon SM
Methods Mol Biol; 2009; 510():337-46. PubMed ID: 19009273
[TBL] [Abstract][Full Text] [Related]
36. Recombinant adenoviral vector expressing HCV NS4 induces protective immune responses in a mouse model of Vaccinia-HCV virus infection: a dose and route conundrum.
Singh S; Vedi S; Li W; Samrat SK; Kumar R; Agrawal B
Vaccine; 2014 May; 32(23):2712-21. PubMed ID: 24631092
[TBL] [Abstract][Full Text] [Related]
37. Development of an adenovirus vector lacking the expression of virus-associated RNAs.
Machitani M; Katayama K; Sakurai F; Matsui H; Yamaguchi T; Suzuki T; Miyoshi H; Kawabata K; Mizuguchi H
J Control Release; 2011 Sep; 154(3):285-9. PubMed ID: 21703313
[TBL] [Abstract][Full Text] [Related]
38. Utilization of RNA polymerase I promoter and terminator sequences to develop a DNA transfection system for the study of hepatitis C virus internal ribosomal entry site-dependent translation.
Oem JK; Xiang Z; Zhou Y; Babiuk LA; Liu Q
J Clin Virol; 2007 Sep; 40(1):55-9. PubMed ID: 17632032
[TBL] [Abstract][Full Text] [Related]
39. Enhanced transduction efficiency of fiber-substituted adenovirus vectors by the incorporation of RGD peptides in two distinct regions of the adenovirus serotype 35 fiber knob.
Matsui H; Sakurai F; Katayama K; Kurachi S; Tashiro K; Sugio K; Kawabata K; Mizuguchi H
Virus Res; 2011 Jan; 155(1):48-54. PubMed ID: 20801174
[TBL] [Abstract][Full Text] [Related]
40. Transfection of HepG2 cells with infectious hepatitis C virus genome.
Dash S; Halim AB; Tsuji H; Hiramatsu N; Gerber MA
Am J Pathol; 1997 Aug; 151(2):363-73. PubMed ID: 9250150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
